365 related articles for article (PubMed ID: 12509401)
1. Essential role of phosphatidylinositol 3-kinase-dependent CCAAT/enhancer binding protein beta activation in the induction of glutathione S-transferase by oltipraz.
Kang KW; Cho IJ; Lee CH; Kim SG
J Natl Cancer Inst; 2003 Jan; 95(1):53-66. PubMed ID: 12509401
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of the oxidized metabolites of oltipraz on the activation of CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 for GSTA2 gene induction.
Ko MS; Lee SJ; Kim JW; Lim JW; Kim SG
Drug Metab Dispos; 2006 Aug; 34(8):1353-60. PubMed ID: 16714377
[TBL] [Abstract][Full Text] [Related]
3. Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation.
Lee SJ; Kim SG
Mol Pharmacol; 2006 Jan; 69(1):385-96. PubMed ID: 16246908
[TBL] [Abstract][Full Text] [Related]
4. Activation of CCAAT/enhancer-binding protein beta by 2'-amino-3'-methoxyflavone (PD98059) leads to the induction of glutathione S-transferase A2.
Kang KW; Park EY; Kim SG
Carcinogenesis; 2003 Mar; 24(3):475-82. PubMed ID: 12663507
[TBL] [Abstract][Full Text] [Related]
5. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
Park EY; Cho IJ; Kim SG
Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
[TBL] [Abstract][Full Text] [Related]
6. Oltipraz inhibits 3-methylcholanthrene induction of CYP1A1 by CCAAT/enhancer-binding protein activation.
Cho IJ; Kim SG
J Biol Chem; 2003 Nov; 278(45):44103-12. PubMed ID: 12941938
[TBL] [Abstract][Full Text] [Related]
7. Ceramide, an apoptotic rheostat, inhibits CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 activation: the role in glutathione S-transferase A2 gene repression.
Park IN; Cho IJ; Kim SG
Drug Metab Dispos; 2004 Sep; 32(9):893-7. PubMed ID: 15319326
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression.
Ki SH; Cho IJ; Choi DW; Kim SG
Mol Cell Biol; 2005 May; 25(10):4150-65. PubMed ID: 15870285
[TBL] [Abstract][Full Text] [Related]
9. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
Cho IJ; Ki SH; Brooks C; Kim SG
Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
[TBL] [Abstract][Full Text] [Related]
10. Oltipraz promotion of liver regeneration after partial hepatectomy: The role of PI3-kinase-dependent C/EBPbeta and cyclin E regulation.
Cho IJ; Sung DK; Kang KW; Kim SG
Arch Pharm Res; 2009 Apr; 32(4):625-35. PubMed ID: 19407981
[TBL] [Abstract][Full Text] [Related]
11. Phase II enzyme induction by alpha-lipoic acid through phosphatidylinositol 3-kinase-dependent C/EBPs activation.
Ki SH; Kim SG
Xenobiotica; 2008 Jun; 38(6):587-604. PubMed ID: 18570160
[TBL] [Abstract][Full Text] [Related]
12. Ceramide negatively regulates glutathione S-transferase gene transactivation via repression of hepatic nuclear factor-1 that is degraded by the ubiquitin proteasome system.
Park IN; Cho IJ; Kim SG
Mol Pharmacol; 2004 Jun; 65(6):1475-84. PubMed ID: 15155840
[TBL] [Abstract][Full Text] [Related]
13. Differential hepatic GSTA2 expression of arylalkyl isothiocyanates in vivo and in vitro: the molecular mechanism of gene induction by phenethyl isothiocyanate.
Gum SI; Cho MK
Mol Nutr Food Res; 2013 Dec; 57(12):2223-32. PubMed ID: 24039128
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the rat glutathione S-transferase A2 gene by glucocorticoids: crosstalk through C/EBPs.
Falkner KC; Prough RA
Drug Metab Rev; 2007; 39(2-3):401-18. PubMed ID: 17786629
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB activation by the chemopreventive dithiolethione oltipraz is exerted through stimulation of MEKK3 signaling.
Nho CW; O'Dwyer PJ
J Biol Chem; 2004 Jun; 279(25):26019-27. PubMed ID: 15047705
[TBL] [Abstract][Full Text] [Related]
16. ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma.
Hu J; Roy SK; Shapiro PS; Rodig SR; Reddy SP; Platanias LC; Schreiber RD; Kalvakolanu DV
J Biol Chem; 2001 Jan; 276(1):287-97. PubMed ID: 10995751
[TBL] [Abstract][Full Text] [Related]
17. Cell-based studies reveal differences in glutathione S-transferase induction between oltipraz and tert-butylhydroquinone.
Lamb JG; Franklin MR
J Biochem Mol Toxicol; 2002; 16(4):154-61. PubMed ID: 12242683
[TBL] [Abstract][Full Text] [Related]
18. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
Noh K; Kim YM; Kim YW; Kim SG
Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor activates CCAAT enhancer binding protein and cell replication via PI3-kinase pathway.
Cho MK; Kim SG
Hepatology; 2003 Mar; 37(3):686-95. PubMed ID: 12601366
[TBL] [Abstract][Full Text] [Related]
20. Enhanced CCAAT/enhancer-binding protein beta-liver-enriched inhibitory protein production by Oltipraz, which accompanies CUG repeat-binding protein-1 (CUGBP1) RNA-binding protein activation, leads to inhibition of preadipocyte differentiation.
Bae EJ; Kim SG
Mol Pharmacol; 2005 Sep; 68(3):660-9. PubMed ID: 15961673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
